MCID: GST023
MIFTS: 56

Gastric Ulcer malady

Categories: Gastrointestinal diseases

Aliases & Classifications for Gastric Ulcer

Aliases & Descriptions for Gastric Ulcer:

Name: Gastric Ulcer 12 52 14 69
Acute Gastric Ulcer Without Mention of Hemorrhage or Perforation, Without Mention of Obstruction 12
Chronic Gastric Ulcer Without Hemorrhage and Without Perforation but with Obstruction 12
Chronic Gastric Ulcer Without Mention of Hemorrhage or Perforation, with Obstruction 12
Acute Gastric Ulcer with Hemorrhage and Perforation, Without Mention of Obstruction 12
Acute Gastric Ulcer Without Hemorrhage, Without Perforation and Without Obstruction 12
Acute Gastric Ulcer with Hemorrhage and with Perforation but Without Obstruction 12
Acute Gastric Ulcer with Hemorrhage, with Perforation and with Obstruction 12
Acute Gastric Ulcer with Hemorrhage and Perforation, with Obstruction 12
Chronic Gastric Ulcer Without Hemorrhage and Without Perforation 12
Acute Gastric Ulcer Without Hemorrhage and Without Perforation 12
Acute Gastric Ulcer with Hemorrhage and Perforation [dup] 12
Acute Gastric Ulcer with Perforation, with Obstruction 12
Acute Gastric Ulcer with Hemorrhage, with Obstruction 12
Acute Gastric Ulcer with Haemorrhage and Perforation 12
Acute Gastric Ulcer with Perforation and Obstruction 12
Acute Gastric Ulcer with Hemorrhage and Obstruction 12
Acute Gastric Ulcer with Hemorrhage and Perforation 12
Acute Gastric Ulcer with Perforation 12
Bleeding Acute Gastric Ulcer 12
Stomach Ulcer 42

Classifications:



Summaries for Gastric Ulcer

MalaCards based summary : Gastric Ulcer, also known as acute gastric ulcer without mention of hemorrhage or perforation, without mention of obstruction, is related to hepatocellular carcinoma and choroiditis. An important gene associated with Gastric Ulcer is HRH2 (Histamine Receptor H2), and among its related pathways/superpathways are PEDF Induced Signaling and Akt Signaling. The drugs Amoxicillin and Clarithromycin have been mentioned in the context of this disorder. Affiliated tissues include endothelial, liver and heart, and related phenotypes are digestive/alimentary and neoplasm

Related Diseases for Gastric Ulcer

Diseases related to Gastric Ulcer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 217)
id Related Disease Score Top Affiliating Genes
1 hepatocellular carcinoma 29.6 IL1B IL1RN
2 choroiditis 29.3 CXCL8 IL1B TNF
3 bacterial gastritis 29.1 CXCL8 GAST HRH2 IL1B IL1RN PTGS2
4 peptic ulcer disease 11.0
5 chronic erosive gastritis 11.0
6 gastritis 10.2
7 bladder diffuse clear cell adenocarcinoma 10.2 EGF FGF2
8 intussusception 10.2 IL1B TNF
9 breast cystic hypersecretory carcinoma 10.2 GAST HRH2 PTGS2
10 oculomotor nerve paralysis 10.2 CXCL8 IL1B
11 primary non-gestational choriocarcinoma of ovary 10.2 CXCL8 PTGS2
12 common peroneal nerve lesion 10.2 CXCL8 IL1B
13 hidradenitis 10.2 CXCL8 IL1B PTGS2
14 tau syndrome 10.2 IL1B TNF
15 stocco dos santos syndrome 10.2 IL1B TNF
16 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 10.2 IL1B TNF
17 urethral verrucous carcinoma 10.1 FGF2 HGF PTGS2
18 coronary arterial fistulas 10.1 CXCL8 IL1RN
19 twin-to-twin transfusion syndrome 10.1 IL1B TNF
20 duodenitis 10.1
21 nevoid hypermelanosis, linear and whorled 10.1 EGF FGF2 PTGS2
22 mucositis 10.1
23 conidiobolomycosis 10.1 CXCL8 TNF
24 bipolar i disorder 10.1 FGF2 IL1B TNF
25 degenerative disc disease 10.1 HGF TNF
26 chondrodysplasia punctata, rhizomelic, type 1 10.1 CYP2C19 IL1B PTGS2
27 egg allergy 10.1 IL1B IL1RN
28 warthin tumor 10.1 IL1B IL1RN TNF
29 dextrocardia 10.1 IL1B IL1RN TNF
30 benign neonatal seizures 10.1 IL1B IL1RN TNF
31 gonococcal endophthalmia 10.1 IL1B IL1RN TNF
32 keratoconus 10.1 IL1B IL1RN TNF
33 motility-related diarrhea 10.1 IL1B IL1RN TNF
34 cushing's syndrome 10.1 PTGS2 TFF1
35 immunoglobulin g deficiency 10.1 IL1B IL1RN TNF
36 amyotrophic lateral sclerosis type 14 10.1 CXCL8 IL1B TNF
37 parkinson disease 11 10.1 CXCL8 IL1B TNF
38 thymic neuroendocrine carcinoma 10.1 CXCL8 TNF
39 acquired thrombocytopenia 10.1 CXCL8 IL1B TNF
40 inappropriate adh syndrome 10.1 CXCL8 IL1B TNF
41 ovarian cystic teratoma 10.1 CXCL8 IL1B TNF
42 epidermolysis bullosa simplex, sutosomal recessive 2 10.1 CXCL8 FGF2 HGF
43 labyrinthitis 10.1 CXCL8 IL1B TNF
44 atrophy of prostate 10.1 CXCL8 IL1B TNF
45 blepharochalasis 10.1 CXCL8 IL1B TNF
46 chordoid meningioma 10.1 CXCL8 IL1B TNF
47 nasopharyngitis 10.1 CXCL8 IL1B TNF
48 cataract 10.1 HGF IL1B TNF
49 infancy electroclinical syndrome 10.1 CXCL8 IL1B TNF
50 solitary plasmacytoma of chest wall 10.1 GAST PTGS2 TFF1

Graphical network of the top 20 diseases related to Gastric Ulcer:



Diseases related to Gastric Ulcer

Symptoms & Phenotypes for Gastric Ulcer

MGI Mouse Phenotypes related to Gastric Ulcer:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.5 EGF GAST HRH2 PTGS1 PTGS2 TFF1
2 neoplasm MP:0002006 9.17 FGF2 GAST IL1B PTGS1 PTGS2 TFF1

Drugs & Therapeutics for Gastric Ulcer

Drugs for Gastric Ulcer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 436)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3 26787-78-0 33613 2171
2
Clarithromycin Approved Phase 4,Phase 2,Phase 3 81103-11-9 84029
3
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 103577-45-3 3883
4
Metronidazole Approved Phase 4,Phase 2,Phase 3 443-48-1 4173
5
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 117976-89-3 5029
6
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
7
Celecoxib Approved, Investigational Phase 4,Phase 3 169590-42-5 2662
8
Naproxen Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22204-53-1 1302 156391
9
Ecabet Approved, Investigational Phase 4 33159-27-2, 86408-72-2 65781
10
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 73590-58-6 4594
11
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
12
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
13
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 161796-78-7, 119141-88-7 4594 9579578
14
Sucralfate Approved Phase 4 54182-58-0
15
Famotidine Approved Phase 4,Phase 3,Phase 2,Phase 1 76824-35-6 3325
16
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
17
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 616-91-1 12035
18
Acetaminophen Approved Phase 4 103-90-2 1983
19
Somatostatin Approved Phase 4,Phase 2 38916-34-6, 51110-01-1 53481605
20
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
21
Sulpiride Approved Phase 4 15676-16-1 5355
22
Colchicine Approved Phase 4 64-86-8 6167 2833
23
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
24
Remifentanil Approved Phase 4 132875-61-7 60815
25
Ranitidine Approved Phase 4,Phase 3,Phase 2,Phase 1 66357-59-3, 66357-35-5 3001055
26
Coal tar Approved Phase 4 8007-45-2
27
Loxoprofen Approved Phase 4 68767-14-6, 80382-23-6 3965
28
Ethanol Approved Phase 4 64-17-5 702
29
Levofloxacin Approved, Investigational Phase 4,Phase 3 100986-85-4 149096
30
Ofloxacin Approved Phase 4,Phase 3 82419-36-1 4583
31
Terlipressin Approved, Investigational Phase 4 14636-12-5 72081
32
Potassium Citrate Approved, Vet_approved Phase 4,Phase 3
33
Tetracycline Approved, Vet_approved Phase 4,Phase 3,Phase 2 60-54-8 5353990
34
Cimetidine Approved Phase 4,Phase 3 51481-61-9 2756
35
Domperidone Approved, Investigational, Vet_approved Phase 4 57808-66-9 3151
36
Dopamine Approved Phase 4,Phase 2 51-61-6, 62-31-7 681
37
Metoclopramide Approved, Investigational Phase 4,Phase 2 364-62-5 4168
38
Nizatidine Approved Phase 4,Phase 1 76963-41-2 3033637
39
Dipyridamole Approved Phase 4 58-32-2 3108
40
Guaifenesin Approved, Vet_approved Phase 4,Phase 3 93-14-1 3516
41
Menthol Approved Phase 4,Phase 3 2216-51-5 16666
42
Furazolidone Approved, Vet_approved Phase 4 67-45-8 3435 5323714
43
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
44
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
45
Magnesium Hydroxide Approved Phase 4,Phase 1 1309-42-8
46
Ibuprofen Approved Phase 4,Phase 3,Phase 1 15687-27-1 3672
47
Fluorouracil Approved Phase 4,Phase 2 51-21-8 3385
48
Infliximab Approved Phase 4 170277-31-3
49
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3 564-25-0 54671203
50
Vedolizumab Approved Phase 4,Phase 3 943609-66-3

Interventional clinical trials:

(show top 50) (show all 701)
id Name Status NCT ID Phase
1 H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection Unknown status NCT00926809 Phase 4
2 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4
3 The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients Unknown status NCT01397240 Phase 4
4 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Unknown status NCT02355236 Phase 4
5 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4
6 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4
7 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication Unknown status NCT01464060 Phase 4
8 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4
9 Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer Unknown status NCT00471029 Phase 4
10 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
11 Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia Unknown status NCT00978159 Phase 4
12 Gastric Functions & Proton Pump Inhibitor( PPI) Study Unknown status NCT00951431 Phase 4
13 Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection Unknown status NCT02249546 Phase 4
14 The Effects of Reducing Stomach Acid on Post-Tonsillectomy Pain Unknown status NCT00472186 Phase 4
15 Early Feeding Following Ligation of Acute Bleeding Varices Unknown status NCT01287702 Phase 4
16 Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB) Unknown status NCT01123031 Phase 4
17 Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients Unknown status NCT02456012 Phase 4
18 Helicobacter Pylori Empiric Treatment in Ulcer Bleeding Unknown status NCT00687336 Phase 4
19 PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms Unknown status NCT02476097 Phase 4
20 PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena Unknown status NCT00526006 Phase 4
21 Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding Unknown status NCT00861640 Phase 4
22 Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy Unknown status NCT01572597 Phase 4
23 Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy Completed NCT00272467 Phase 4
24 Post-Marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer Completed NCT00233389 Phase 4
25 A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium Completed NCT00125736 Phase 4
26 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4
27 Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer Completed NCT00239551 Phase 4
28 An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium Completed NCT00428701 Phase 4
29 Pharmacogenetics of Gastrointestinal Bleeding Completed NCT00190255 Phase 4
30 Colchicine Or Naproxen Treatment for ACute gouT Completed NCT01994226 Phase 4
31 Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections Completed NCT01599273 Phase 4
32 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
33 Opioid-induced Hyperalgesia After Remifentanil Infusion Completed NCT01702389 Phase 4
34 Argon Plasma Coagulation for Bleeding Peptic Ulcers Completed NCT02241044 Phase 4
35 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4
36 Gastric pH in Critically Ill Patients Completed NCT00590928 Phase 4
37 The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers Completed NCT00594867 Phase 4
38 Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers Completed NCT00279123 Phase 4
39 Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers Completed NCT00778193 Phase 4
40 Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit Completed NCT00633035 Phase 4
41 Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Completed NCT00608712 Phase 4
42 Fast-track Surgery for Perforated Peptic Ulcers Completed NCT01620671 Phase 4
43 Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection Completed NCT00844675 Phase 4
44 Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot Completed NCT02536989 Phase 4
45 A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia Completed NCT00702871 Phase 4
46 Treatment of Zollinger-Ellison Syndrome With Prevacid Completed NCT00204373 Phase 4
47 Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection Completed NCT00656968 Phase 4
48 A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn Completed NCT00237367 Phase 4
49 A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) Completed NCT00216489 Phase 4
50 Study Of Celecoxib In Healthy Subjects Completed NCT00994461 Phase 4

Search NIH Clinical Center for Gastric Ulcer

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: stomach ulcer

Genetic Tests for Gastric Ulcer

Anatomical Context for Gastric Ulcer

MalaCards organs/tissues related to Gastric Ulcer:

39
Endothelial, Liver, Heart, Testes, Skin, Pancreas, Lung

Publications for Gastric Ulcer

Articles related to Gastric Ulcer:

(show top 50) (show all 768)
id Title Authors Year
1
Protective effects of bilobalide against ethanol-induced gastric ulcer in vivo/vitro. ( 27903426 )
2017
2
Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. ( 28049442 )
2017
3
Enhancement of Gastric Ulcer Healing and Angiogenesis by Hepatocyte Growth Factor Gene Mediated by Attenuated Salmonella in Rats. ( 28049228 )
2017
4
Gastritis and Gastric Ulcers in Working Dogs. ( 27092307 )
2016
5
Drug-disease interactions: narrative review of aspirin in gastric ulcer. ( 27322160 )
2016
6
Anti-oxidative, anti-secretory and anti-inflammatory activities of the extract from the root bark of Lycium chinense (Cortex Lycii) against gastric ulcer in mice. ( 26972100 )
2016
7
Potential role of probiotics in the management of gastric ulcer. ( 27347010 )
2016
8
Protective effect of hydro-alcoholic extract of Ruta graveolens Linn. leaves on indomethacin and pylorus ligation-induced gastric ulcer in rats. ( 27297508 )
2016
9
Utilisation of the falciform ligament pedicle flap as an alternative approach for the repair of a perforated gastric ulcer. ( 27102415 )
2016
10
Evaluation of protective effects of costunolide and dehydrocostuslactone on ethanol-induced gastric ulcer in mice based on multi-pathway regulation. ( 26970604 )
2016
11
Modified pectic polysaccharide from turmeric (Curcuma longa): A potent dietary component against gastric ulcer. ( 26794747 )
2016
12
Acute thrombosis of a transplanted renal artery after gastric ulcer bleeding in a patient with a long-term well-functioning renal allograft: A case report and literature review. ( 27472705 )
2016
13
Successful treatment of a primary gastric plasmacytoma mimicking intractable gastric ulcer by using high-dose dexamethasone therapy: a case report. ( 27036197 )
2016
14
Quercetin attenuates, indomethacin-induced acute gastric ulcer in rats. ( 27813628 )
2016
15
Protective Effect of Cod (Gadus macrocephalus) Skin Collagen Peptides on Acetic Acid-Induced Gastric Ulcer in Rats. ( 27219644 )
2016
16
Diversity of the Gastric Microbiota in Thoroughbred Racehorses Having Gastric Ulcer. ( 26809803 )
2016
17
Gastric Anisakiasis with a Gastric Ulcer. ( 27980274 )
2016
18
Gastroprotective effects of sulforaphane and thymoquinone against acetylsalicylic acid-induced gastric ulcer in rats. ( 27363643 )
2016
19
Splenic artery pseudoaneurysm causing brisk upper-GIA bleedA fromA gastric ulcer. ( 26802194 )
2016
20
Re: Double pylorus from a chronic gastric ulcer: an interesting and rare case. ( 27109304 )
2016
21
Interaction of lafutidine in binding to human serum albumin in gastric ulcer therapy: STD-NMR, WaterLOGSY-NMR, NMR relaxation times, Tr-NOESY, molecule docking, and spectroscopic studies. ( 27457418 )
2016
22
A rare presentation of gastric mucormycosis presenting as perforated gastric ulcer in pregnancy. ( 27728458 )
2016
23
A bleeding gastric ulcer caused by anisakiasis. ( 27366042 )
2016
24
Epstein-Barr virus gastric ulcer associated with ruxolitinib. ( 27411541 )
2016
25
Gastric ulcer penetrating the liver. ( 26987967 )
2016
26
The gastroprotective effect of Memora nodosa roots against experimental gastric ulcer in mice. ( 27411070 )
2016
27
Dietary composition influences incidence of Helicobacter pylori-induced iron deficiency anemia and gastric ulceration. ( 27620719 )
2016
28
A case of left subphrenic abscess caused by gastric ulcer penetration that was successfully treated with endoscopic transgastric drainage. ( 27916771 )
2016
29
Nebivolol prevents indomethacin-induced gastric ulcer in rats. ( 27224860 )
2016
30
Gastroprotective Effect of Combination of Hot Water Extracts of Licorice (Glycyrrhiza glabra), Pulasari Stem Bark (Alyxia reinwardtii), and Sembung Leaf (Blumea balsamifera) Against Aspirin-Induced Gastric Ulcer Model Rats. ( 26976086 )
2016
31
Therapeutic and recurrence-preventing effects of Qi-Replenishing and Blood-Activating Formula in rats with acetic acid-induced gastric ulcer. ( 26851793 )
2016
32
Management of Giant Gastric Ulcer Perforation: Report of a Case and Review of the Literature. ( 28050305 )
2016
33
Gastroprotective effects of Kangfuxin-against ethanol-induced gastric ulcer via attenuating oxidative stress and ER stress in mice. ( 27983966 )
2016
34
Synthesis and biological evaluation of 3, 8-dimethyl-5-isopropylazulene derivatives as anti-gastric ulcer agent. ( 26938488 )
2016
35
Misplaced "bear claw" in a bleeding gastric ulcer: What next? ( 26979161 )
2016
36
Anti-ulcerogenic effect of cavidine against ethanol-induced acute gastric ulcer in mice and possible underlying mechanism. ( 27380619 )
2016
37
Gastroprotective effect of garlic in indomethacin induced gastric ulcer in rats. ( 27158056 )
2016
38
Antiulcer mechanisms of Vernonia condensata Baker: A medicinal plant used in the treatment of gastritis and gastric ulcer. ( 26956376 )
2016
39
Gastroprotective effects of several H2RAs on ibuprofen-induced gastric ulcer in rats. ( 26883979 )
2016
40
Piper umbellatum L.: a medicinal plant with gastric-ulcer protective and ulcer healing effects in experimental rodent models. ( 27396348 )
2016
41
Erratum: Utilisation of the falciform ligament pedicle flap as an alternative approach for the repair of a perforated gastric ulcer. ( 27664223 )
2016
42
Therapeutic effect of low molecular weight chitosan containing sepia ink on ethanol-induced gastric ulcer in rats. ( 28076505 )
2016
43
Gastric ulcer that turned out to be metastasis of a synovial sarcoma: A case report and literature review. ( 28087966 )
2016
44
Video of the month: Hemostasis for spurting bleeding from a gastric ulcer using argon plasma coagulation. ( 25646906 )
2015
45
A Case of Proton Pump Inhibitor-Resistant Multiple Gastric Ulcers Caused by Eosinophilic Gastroenteritis. ( 26272422 )
2015
46
Massive Upper Gastrointestinal Bleeding from a Splenic Artery Pseudoaneurysm Caused by a Penetrating Gastric Ulcer: Case Report and Review of Literature. ( 26309450 )
2015
47
Multiple repeats of Helicobacter pylori CagA EPIYA-C phosphorylation sites predict risk of gastric ulcer in Iran. ( 26408373 )
2015
48
Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4. ( 26522475 )
2015
49
Nerve growth factor injected into the gastric ulcer base incorporates into endothelial, neuronal, glial and epithelial cells: implications for angiogenesis, mucosal regeneration and ulcer healing. ( 26348086 )
2015
50
Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidences. ( 26558146 )
2015

Variations for Gastric Ulcer

Expression for Gastric Ulcer

Search GEO for disease gene expression data for Gastric Ulcer.

Pathways for Gastric Ulcer

Pathways related to Gastric Ulcer according to GeneCards Suite gene sharing:

(show all 44)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.55 CXCL8 EGF HGF IL1B PTGS1 PTGS2
2
Show member pathways
13.3 CXCL8 EGF FGF2 HGF IL1B TNF
3
Show member pathways
13.17 CXCL8 EGF FGF2 HGF IL1B TNF
4
Show member pathways
13.12 CXCL8 EGF FGF2 HGF IL1B IL1RN
5
Show member pathways
12.88 CXCL8 IL1B IL1RN PTGS2 TNF
6 12.61 EGF FGF2 IL1B TNF
7
Show member pathways
12.55 EGF FGF2 HGF IL1B TNF
8 12.49 CXCL8 EGF FGF2 HGF PTGS2
9 12.37 IL1B IL1RN PTGS1 PTGS2 TNF
10
Show member pathways
12.23 IL1B PTGS1 PTGS2 TNF
11
Show member pathways
12.22 CXCL8 IL1B PTGS2 TNF
12
Show member pathways
12.21 EGF HRH2 PTGS2 TFF1
13
Show member pathways
12.12 CXCL8 IL1B PTGS2 TNF
14
Show member pathways
12.05 CXCL8 IL1B TNF
15 12.02 CXCL8 IL1B IL1RN TNF
16 11.98 EGF FGF2 HGF
17 11.97 CXCL8 EGF TNF
18
Show member pathways
11.9 CYP2C19 PTGS1 PTGS2
19 11.88 CYP2C19 PTGS1 PTGS2
20 11.86 IL1B PTGS2 TNF
21 11.84 CXCL8 IL1B PTGS2 TNF
22 11.81 CXCL8 IL1B TNF
23 11.79 CXCL8 IL1B TNF
24 11.75 CXCL8 IL1B TNF
25 11.73 FGF2 HGF PTGS2
26 11.71 CXCL8 IL1B PTGS2 TNF
27
Show member pathways
11.67 CXCL8 PTGS2 TNF
28 11.66 CXCL8 IL1B TNF
29 11.49 CXCL8 IL1B TNF